PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29188801-1	2018	Among the somatostatin analogues, octreotide (OCT) is the most commonly used in clinic via intravenous or subcutaneous injection to treat various diseases caused by increased secretion of growth hormone, gastrin or insulin.	Octreotide	34-44	growth hormone	Mus musculus	188-202	
29188801-1	2018	Among the somatostatin analogues, octreotide (OCT) is the most commonly used in clinic via intravenous or subcutaneous injection to treat various diseases caused by increased secretion of growth hormone, gastrin or insulin.	Octreotide	46-49	growth hormone	Mus musculus	188-202	
32856736-10	2020	Crucially, high miR-34a expression significantly blunted octreotide-mediated GH inhibition and anti-proliferative effects.	Octreotide	57-67	growth hormone	Mus musculus	77-79	
10639570-5	2000	Administration of the somatostatin analogue octreotide in a manner previously shown to acutely suppress the growth hormone - IGF-I axis increased mammary gland TGF-beta1 expression approximately 3-fold.	Octreotide	44-54	growth hormone	Mus musculus	108-122